LiuT.C.Y., LiuY.Y., WeiE.X.et al.2012. Photobiomodulation on stress. Int. J. Photoenergy10.1155/2012/628649(http://www.hindawi.com/journals/ijp/aip/628649).
2.
XuY.Y., LiuT.C.Y., ChengL.2012. Photobiomodulation process. Int. J. Photoenergy10.1155/2012/374861(http://www.hindawi.com/journals/ijp/2012/374861).
3.
LuoL., SunZ., ZhangL.et al.2013. Effects of low-level laser therapy on ROS homeostasis and expression of IGF-1 and TGF-β1 in skeletal muscle during the repair process. Lasers Med. Sci., 28:725–734.
4.
AssisL., MorettiA.I., AbrahãoT.B.et al.2013. Low-level laser therapy (808 nm) contributes to muscle regeneration and prevents fibrosis in rat tibialis anterior muscle after cryolesion. Lasers Med. Sci., 28:947–955.
MacIntyreD.L., ReidW.D., McKenzieD.C.1995. Delayed muscle soreness. The inflammatory response to muscle injury and its clinical implications. Sports Med., 20:24–40.
7.
FuD., LiuC., LiaoB.et al.2011. Effects of niacin supplementation on SIRT1, p65 and 20S proteolytic enzyme in skeletal muscle of rats after a bout of non-exhaustive eccentric exercise. China Sport Science, 31:32–45.
8.
LiuT.C.Y., FuD.R., LiuX.G.et al.2011. Laser homeostatics on delayed onset muscle soreness. J. Phys. Conf. Ser., 277:012021.
9.
KinnulaV.L., MyllärniemiM.2008. Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis. Antioxid. Redox Signal, 10:727–738.
10.
KaiH., MoriT., TokudaK.et al.2006. Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II. Hypertens Res., 29:711–718.
11.
FredmanG., LiY., DalliJ.et al.2012. Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA. Sci. Rep., 2:639.
12.
MeyerM., MüllerA.K., YangJ.et al.2011. The role of chronic inflammation in cutaneous fibrosis: fibroblast growth factor receptor deficiency in keratinocytes as an example. J. Investig. Dermatol. Symp. Proc., 15:48–52.
13.
XingZ., OhkawaraY., JordanaM.et al.1996. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J. Clin. Invest., 97:1102–1110.
14.
YuJ., HuiA.Y., ChuE.S.et al.2009. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats. Liver Int., 29:25–36.
15.
FriedmanS.L., SheppardD., DuffieldJ.S.et al.2013. Therapy for fibrotic diseases: nearing the starting line. Sci. Transl. Med., 5:167sr1.
16.
HigashiK., OdaT., KushiyamaT.et al.2010. Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice. Nephrology (Carlton), 15:327–335.
17.
BhattacharyyaS., KelleyK., MelichianD.S.et al.2012. Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am. J. Pathol., 182:192–205.
18.
JinY., MurakamiN., SaitoY.et al.2000. Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration. Acta Neuropathol., 99:619–627.
19.
IacobellisA., MarcelliniM., AndriulliA.et al.2006. Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis. World J. Gastroenterol., 12:7821–7825.
20.
JacksonW.M., NestiL.J., TuanR.S.2012. Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res. Ther., 3:20.
